Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials

Cancer Patients ◽

Phase Ii ◽

Meta Analysis ◽

Parp Inhibitors ◽

Controlled Trials ◽

Gastrointestinal events with PARP inhibitors in cancer patients: A meta‐analysis of phase II/III randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13300 ◽

2020 ◽

Author(s):

Wenxia Sun ◽

Jing Li ◽

Zhifeng Zhang ◽

Xueyan Su

Keyword(s):

Cancer Patients ◽

Phase Ii ◽

Meta Analysis ◽

Parp Inhibitors ◽

Controlled Trials ◽

Randomized Controlled ◽

Gastrointestinal Events

Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials

Journal of Chemotherapy ◽

10.1080/1120009x.2021.1947022 ◽

2021 ◽

pp. 1-14

Author(s):

Gang Yin ◽

Ling Zhao

Keyword(s):

Systematic Review ◽

Monoclonal Antibodies ◽

Cancer Patients ◽

Phase Ii ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Anti Vegf

PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials

Annals of Oncology ◽

10.1016/j.annonc.2021.04.023 ◽

2021 ◽

Author(s):

P.-M. Morice ◽

I. Ray-Coquard ◽

K.N. Moore ◽

V. Diéras ◽

J. Alexandre

Keyword(s):

Systematic Review ◽

Cancer Patients ◽

Meta Analysis ◽

Parp Inhibitors ◽

Second Primary ◽

Controlled Trials ◽

Randomized Controlled ◽

Second Primary Malignancies

Physiologic and psychologic adaptation to exercise interventions in lung cancer patients undergoing chemotherapy: a systematic review and meta-analysis of randomized controlled trials

Supportive Care in Cancer ◽

10.1007/s00520-020-05939-3 ◽

2021 ◽

Author(s):

Junga Lee

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Meta Analysis ◽

Controlled Trials ◽

Exercise Interventions ◽

Lung Cancer Patients ◽

Randomized Controlled ◽

Adaptation To Exercise

Effectiveness of Acceptance and Commitment Therapy for mental Illness in cancer patients: A systematic Review and meta‐analysis of randomized controlled trials

International Journal of Clinical Practice ◽

10.1111/ijcp.13982 ◽

2021 ◽

Author(s):

Zhihong Li ◽

Yanfei Li ◽

Liping Guo ◽

Meixuan Li ◽

Kehu Yang

Keyword(s):

Systematic Review ◽

Mental Illness ◽

Cancer Patients ◽

Acceptance And Commitment Therapy ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Commitment Therapy ◽

Acceptance And Commitment

Olanzapine combined with 5-HT3 RA plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in cancer patients: A systematic review and meta-analysis of randomized controlled trials

Annals of Oncology ◽

10.1093/annonc/mdz434 ◽

2019 ◽

Vol 30 ◽

pp. ix140

Author(s):

J.-G. Zhou ◽

S.-H. Jin ◽

H. Ma

Keyword(s):

Systematic Review ◽

Cancer Patients ◽

Meta Analysis ◽

Nausea And Vomiting ◽

Controlled Trials ◽

Randomized Controlled ◽

Prevention And Treatment

Abstract P3-09-02: Optimal anti-emetic choice for breast cancer patients receiving anthracycline and cyclophosphamide-based chemotherapy - A systematic review and network meta-analysis of randomized controlled trials

10.1158/0008-5472.sabcs13-p3-09-02 ◽

2013 ◽

Author(s):

TL Ng ◽

M Clemons ◽

I Kuchuk ◽

J Roscoe ◽

B Hutton

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Meta Analysis ◽

Controlled Trials ◽

Breast Cancer Patients ◽

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2020.102940 ◽

2020 ◽

Vol 149 ◽

pp. 102940

Author(s):

Rafael Caparica ◽

Marco Bruzzone ◽

Georges El Hachem ◽

Marcello Ceppi ◽

Matteo Lambertini ◽

...

Keyword(s):

Systematic Review ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Tract Cancer ◽

Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2020.102040 ◽

2020 ◽

Vol 87 ◽

pp. 102040 ◽

Cited By ~ 1

Author(s):

Ilary Ruscito ◽

Filippo Bellati ◽

Isabelle Ray-Coquard ◽

Mansoor Raza Mirza ◽

Andreas du Bois ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Meta Analysis ◽

Recurrent Ovarian Cancer ◽

Parp Inhibitors ◽

Controlled Trials ◽

Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PLoS ONE ◽

10.1371/journal.pone.0136324 ◽

2015 ◽

Vol 10 (9) ◽

pp. e0136324 ◽

Cited By ~ 16

Author(s):

Fariba Ahmadizar ◽

N. Charlotte Onland-Moret ◽

Anthonius de Boer ◽

Geoffrey Liu ◽

Anke H. Maitland-van der Zee

Keyword(s):

Systematic Review ◽

Adjuvant Therapy ◽

Cancer Patients ◽

Safety Assessment ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽